Global pMDI Use and the Potential Impact of European PFAS Legislation on Access to These Essential Inhaled Medications
- DOI
- 10.1007/s41030-026-00362-1
- Published
- 2026-06
- Container
- Pulmonary Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s41030-026-00362-1,
title = {Global pMDI Use and the Potential Impact of European PFAS Legislation on Access to These Essential Inhaled Medications},
author = {Janwillem W. H. Kocks and Tim Harrison and John P. Bell and Andy Rignall and Mina Khezrian and Omar S. Usmani},
year = {2026},
journal = {Pulmonary Therapy},
doi = {10.1007/s41030-026-00362-1},
url = {https://doi.org/10.1007/s41030-026-00362-1}
}RIS
TY - JOUR TI - Global pMDI Use and the Potential Impact of European PFAS Legislation on Access to These Essential Inhaled Medications AU - Janwillem W. H. Kocks AU - Tim Harrison AU - John P. Bell AU - Andy Rignall AU - Mina Khezrian AU - Omar S. Usmani PY - 2026 JO - Pulmonary Therapy DO - 10.1007/s41030-026-00362-1 UR - https://doi.org/10.1007/s41030-026-00362-1 ER -
APA
Kocks, J. W. H., Harrison, T., Bell, J. P., Rignall, A., Khezrian, M., & Usmani, O. S. (2026). Global pMDI Use and the Potential Impact of European PFAS Legislation on Access to These Essential Inhaled Medications. Pulmonary Therapy. https://doi.org/10.1007/s41030-026-00362-1
Source records
- crossref · retrieved 2026-11-09T22:46:45.766Z